LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • RBC Capital Markets Is Increasing Regeneron Pharmaceuticals (REGN) 2Q12 Rev. Estimate To 293.7 M From 279.8 M 7/24/2012 1:34:36 PM
  • RBC Capital Markets Is Raising Regeneron Pharmaceuticals (REGN) FY12 Rev. Estimate To 1.08 Billion From 1.06 Billion 7/24/2012 1:33:34 PM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $150 Price Target 7/24/2012 8:24:50 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY12 Estimate To 2.51 From 1.97 7/24/2012 8:13:04 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $150 Price Target 5/30/2012 7:31:07 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $150 Price Target 5/7/2012 8:29:55 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $150 Price Target 5/1/2012 8:21:54 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $150 up from $130 Price Target 4/27/2012 9:13:35 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY13 Estimate To 3.34 From 1.08 4/27/2012 8:17:33 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY12 Estimate To 1.97 From 0.28 4/27/2012 8:17:08 AM
  • Regeneron Pharmaceuticals (REGN) Has Raised Its 2012 Revenue Estimate To $500 - $550 Mln From $250 - $300 Mln 4/26/2012 6:48:56 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $130 up from $125 Price Target 4/25/2012 8:04:14 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $125 Price Target 4/13/2012 7:46:55 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Outperform With $125 Price Target 3/30/2012 7:41:08 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap